"**Sustained Release Drugs Market Size And Forecast by 2032**

According to Data Bridge Market Research The global sustained release drugs market size was valued at USD 13.29 billion in 2024 and is projected to reach USD 24.72 billion by 2032, with a CAGR of 8.06% during the forecast period of 2025 to 2032.

Our comprehensive Sustained Release Drugs Market report is ready with the latest trends, growth opportunities, and strategic analysis. https://www.databridgemarketresearch.com/reports/global-sustained-release-drugs-market

Sustained release drugs have gained significant traction in the pharmaceutical industry due to their ability to provide a controlled and prolonged release of medication into the body, ensuring better patient compliance and effectiveness of treatment. The market for sustained release drugs is segmented based on release mechanism, application, and distribution channel. By release mechanism, the market is categorized into oral, injectable, transdermal, and others. The oral segment dominates the market owing to the ease of administration and wide applicability across various therapeutic areas. In terms of application, sustained release drugs find extensive usage in the treatment of cardiovascular diseases, oncology, central nervous system disorders, diabetes, and others. The cardiovascular diseases segment holds a significant share in the market due to the increasing prevalence of heart-related ailments globally. When it comes to distribution channels, hospital pharmacies, retail pharmacies, and online pharmacies play a vital role in the distribution of sustained release drugs to end-users.